For laboratory research use only. Not for human or veterinary use.
⚠ For research purposes only — This certificate relates to the referenced lot only and is not an approval for human or veterinary use.
← Back to NAD+ Spray
All certificates
Atlas LabsQuality Control · Released Records

Certificate of Analysis

DOC QC-COA-0115-A2609 · REV 1
ProductNAD+ Spray
SKUATL-0115
LotA2609
FormatSolution · 750 mg / 15 mL
TestedJul 2026
Retest datePLACEHOLDER
CAS53-84-9
Storage2–8 °C · protected from light
DispositionRELEASED

Test results

Release test results for NAD+ Spray lot A2609
TestMethodSpecificationResultVerdict
AppearanceVisual White to off-white solidClear colourless solution PASS
PurityRP-HPLC, 220 nm ≥ 95.0%Conforms PASS
Net peptide contentHPLC 750 mg / 15 mL ± 2%754 mg / 15 mL PASS
IdentityESI-MS Observed mass conforms to theoreticalConforms PASS
Fentanyl screenImmunoassay Not detectedNot detected PASS
Heavy metalsICP-MS Not detectedNot detected PASS
SterilityPCR No growthNo growth PASS
EndotoxinLAL, USP <85> < 0.5 EU/mL< LOD PASS

Chromatogram · RP-HPLC, 220 nm

12.4 min · Conforms RRT 1.28 · 0.09% 01530 min
FIG 1 · MAIN PEAK 12.4 MIN, Conforms AREA · LARGEST IMPURITY 0.09% · PLACEHOLDER TRACE, REPLACE WITH LAB EXPORT

Conclusion. Lot A2609 of ATL-0115 meets all release specifications and is approved for distribution for laboratory research use only. Testing performed by ILS Laboratories, an independent ISO 17025 accredited laboratory.

Analyst · PLACEHOLDERILS Laboratories · Jul 2026
QC Release · PLACEHOLDERAtlas Labs · Jul 2026
VERIFY THIS DOCUMENT
getatlaspeptides.com/coa/a2609
CODE ATL-A2609-8L2Q